February 9, 2012
Bookmark and Share  




In this week's Eblast we offer the following new postings:

Hepatitis C:

  • Victrelis Warning: Merck has issued a ‘Dear Health Care Professional” letter to alert medical providers that a recently released study of drug-drug interactions between Victrelis (boceprevir) and certain HIV medications were found to lower the blood concentrations of HIV and/or HCV medications.   Click here
  • HIV/HCV Coinfection Guide: This new guide provides basic information about having HIV and hepatitis C coinfection. Click here
  • Stigma Slideshow from our friends at the Haymarket Center in Chicago who do really good work with underserved populations. Click here


Hepatitis and Tattoos:

  • Be sure to check out our Hepatitistattoos.org Website blog to read about the new story on the risk of hepatitis C transmission and tattoos. Click here

HBV and HCV Blog:
Read about the latest and greatest in the news





Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org


**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.